EA201390663A1 - Универсальный гель против сухости влагалища с прямым и отсроченным эффектом - Google Patents

Универсальный гель против сухости влагалища с прямым и отсроченным эффектом

Info

Publication number
EA201390663A1
EA201390663A1 EA201390663A EA201390663A EA201390663A1 EA 201390663 A1 EA201390663 A1 EA 201390663A1 EA 201390663 A EA201390663 A EA 201390663A EA 201390663 A EA201390663 A EA 201390663A EA 201390663 A1 EA201390663 A1 EA 201390663A1
Authority
EA
Eurasian Patent Office
Prior art keywords
vague
direct
extra effect
gel against
against dryness
Prior art date
Application number
EA201390663A
Other languages
English (en)
Other versions
EA026198B1 (ru
Inventor
Альберто Барторелли
Мария Роза Гобби
Original Assignee
Замбон С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Замбон С.П.А. filed Critical Замбон С.П.А.
Publication of EA201390663A1 publication Critical patent/EA201390663A1/ru
Publication of EA026198B1 publication Critical patent/EA026198B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Настоящее изобретение относится к местным вагинальным композициям в форме геля, содержащим медиаторы иммунного ответа, факторы роста, факторы хемотаксиса и антибактериальные/противовирусные факторы, экстрагируемые из молозива коров, и необязательно другие ингредиенты с дополнительной активностью.
EA201390663A 2010-12-09 2011-12-02 Универсальный гель против сухости влагалища с прямым и отсроченным эффектом EA026198B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2010A002260A IT1405998B1 (it) 2010-12-09 2010-12-09 Gel polifunzionale contro la secchezza vaginale ad effetto diretto e ritardato
PCT/EP2011/071612 WO2012076409A1 (en) 2010-12-09 2011-12-02 Multipurpose gel for vaginal dryness with direct and delayed effect

Publications (2)

Publication Number Publication Date
EA201390663A1 true EA201390663A1 (ru) 2013-11-29
EA026198B1 EA026198B1 (ru) 2017-03-31

Family

ID=43736916

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201390663A EA026198B1 (ru) 2010-12-09 2011-12-02 Универсальный гель против сухости влагалища с прямым и отсроченным эффектом

Country Status (26)

Country Link
US (1) US9248151B2 (ru)
EP (1) EP2648739B1 (ru)
JP (1) JP6120774B2 (ru)
CN (1) CN103338778B (ru)
AU (1) AU2011340757B2 (ru)
BR (1) BR112013014081B1 (ru)
CA (1) CA2820403C (ru)
CO (1) CO6781483A2 (ru)
CY (1) CY1118832T1 (ru)
DK (1) DK2648739T3 (ru)
EA (1) EA026198B1 (ru)
ES (1) ES2624766T3 (ru)
HR (1) HRP20170663T1 (ru)
HU (1) HUE033257T2 (ru)
IL (1) IL226764A (ru)
IT (1) IT1405998B1 (ru)
LT (1) LT2648739T (ru)
ME (1) ME02665B (ru)
MX (1) MX341572B (ru)
MY (1) MY160610A (ru)
PL (1) PL2648739T3 (ru)
PT (1) PT2648739T (ru)
RS (1) RS55910B1 (ru)
SI (1) SI2648739T1 (ru)
WO (1) WO2012076409A1 (ru)
ZA (1) ZA201304147B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9555084B2 (en) 2011-12-30 2017-01-31 Innomed S.A. Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3a/C4a, immunoglobulins and chemotactic factors
EP2815757A1 (en) * 2013-06-17 2014-12-24 Hestia Investments Composition for topical use in prevention and treatment of bacterial and fungal infections of skin and mucosa
CN105030872A (zh) * 2015-07-30 2015-11-11 太阳树（厦门）生物工程有限公司 一种玛咖提取物的提取工艺
ITUB20155902A1 (it) 2015-11-25 2017-05-25 Nathura S P A Composizione farmaceutica cicatrizzante per uso topico
NL2017656B1 (nl) * 2016-10-21 2018-04-30 Johan Wagenaar Louis Samenstelling voor slijmvliesherstel
CN107693842B (zh) * 2017-12-05 2020-05-05 湖北美尔丽生物科技有限公司 一种医用耐水凝胶及其制备方法
IT201800002990A1 (it) * 2018-02-23 2019-08-23 Biomedical Res Srl Composizione a base di una miscela di fattori biologici isolata dal colostro e oli vegetali ozonizzati per l’uso nel trattamento di vaginiti e vaginosi
CN112135621A (zh) * 2018-05-04 2020-12-25 宝洁公司 用于治疗***萎缩的组合物和方法
CN112088010A (zh) 2018-05-04 2020-12-15 宝洁公司 用于治疗***干燥的组合物和方法
EP3603626A1 (en) * 2018-07-31 2020-02-05 Mucosa Innovations, S.L. Composition for use in the prevention and/or treatment of the genitourinary mucosa
RS58997B1 (sr) 2018-09-14 2019-08-30 Fazlagic Amira Dr Kompozicija protiv starenja kože intimne regije
CN111744005B (zh) * 2020-06-24 2024-04-26 黑龙江天龙药业有限公司 一种女性下生殖道粘膜保护、再生喷剂及其制备方法
CN112999335A (zh) * 2021-02-26 2021-06-22 王利琼 一种用于女性***预防与治疗各种妇科炎症、抗hpv的缓释水凝胶的制备方法
EP4326068A1 (de) * 2021-04-23 2024-02-28 Thomas Meneghini Desinfektionsmittel und dessen verwendung
CN114588252A (zh) * 2022-04-08 2022-06-07 暨南大学附属第一医院（广州华侨医院） 一种用于缓解***萎缩和干燥症的组合物及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3576117D1 (de) * 1984-09-24 1990-04-05 Michael Mezei Mehrphasige pharmazeutische zusammensetzung.
US20030215506A1 (en) * 2002-05-17 2003-11-20 Kuhrts Eric H Methods and compositions for enhancement of creatine transport
CA2521855A1 (en) * 2003-04-09 2004-10-21 Dolhay Klinika Egeszsegugyi Kft. Feminine hygiene composition comprising an equid milk extract
CN1557340A (zh) * 2004-01-15 2004-12-29 高春平 生长因子和免疫球蛋白制剂
EP1802287A2 (en) * 2004-09-27 2007-07-04 Sigmoid Biotechnologies Limited Minicapsule formulations
US8703198B2 (en) * 2005-03-02 2014-04-22 Aquatrove Biosciences Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof
KR20080013903A (ko) * 2005-05-10 2008-02-13 머레이 걸번 코-어퍼러티브 컴퍼니 리미티드 면역글로불린 분획 및 이것의 제조 방법
KR100509681B1 (ko) * 2005-05-27 2005-08-23 주식회사 렉스진바이오텍 포유동물의 초유 또는 유즙 유래의 유청분리분획을포함하는 성장 촉진용 식품 조성물
ITMI20051777A1 (it) * 2005-09-23 2007-03-24 Pharmaproducts Uk Ltd Composizioni a base di colostro per il trattamento della secchezza vaginale
EP3718532A1 (en) * 2005-12-08 2020-10-07 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections
DK2392343T3 (en) * 2006-07-03 2019-01-28 Perraudin Jean Paul Antimicrobial compositions comprising hypohalite and / or hypothiocyanite and applications thereof
US8268347B1 (en) * 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
JP2009190994A (ja) * 2008-02-13 2009-08-27 Kitasato Institute 抗インフルエンザウイルス剤、及びその有効成分の製造方法
EP2268669B1 (en) * 2008-03-13 2017-10-18 Immuron Limited Bovine Colostrum comprising anti-insulin antibodies for treating Metabolic Disorder diseases.
KR101645957B1 (ko) * 2008-05-15 2016-08-05 더블유. 헬스 엘.피. 분비 면역글로블린이 풍부한 우유 분획 제조방법
IT1392471B1 (it) * 2008-11-25 2012-03-09 Pharmafilm S R L Collutorio in forma di sospensione stabile comprendente microsfere che incorporano un principio attivo.

Also Published As

Publication number Publication date
ITMI20102260A1 (it) 2012-06-10
EA026198B1 (ru) 2017-03-31
CY1118832T1 (el) 2018-01-10
WO2012076409A1 (en) 2012-06-14
CN103338778B (zh) 2018-02-02
MX341572B (es) 2016-08-25
US20140322329A1 (en) 2014-10-30
IT1405998B1 (it) 2014-02-06
ME02665B (me) 2017-06-20
JP6120774B2 (ja) 2017-04-26
ZA201304147B (en) 2014-08-27
JP2013544858A (ja) 2013-12-19
HUE033257T2 (hu) 2017-11-28
IL226764A (en) 2016-12-29
AU2011340757A1 (en) 2013-07-04
AU2011340757B2 (en) 2016-10-27
DK2648739T3 (en) 2017-05-01
BR112013014081A2 (pt) 2016-09-20
PL2648739T3 (pl) 2017-08-31
MY160610A (en) 2017-03-15
BR112013014081B1 (pt) 2020-03-17
EP2648739B1 (en) 2017-02-15
CO6781483A2 (es) 2013-10-31
MX2013006406A (es) 2014-01-31
EP2648739A1 (en) 2013-10-16
PT2648739T (pt) 2017-05-23
CA2820403C (en) 2018-05-01
LT2648739T (lt) 2017-04-25
HRP20170663T1 (hr) 2017-06-30
CA2820403A1 (en) 2012-06-14
RS55910B1 (sr) 2017-09-29
ES2624766T3 (es) 2017-07-17
SI2648739T1 (sl) 2017-05-31
US9248151B2 (en) 2016-02-02
CN103338778A (zh) 2013-10-02

Similar Documents

Publication Publication Date Title
EA201390663A1 (ru) Универсальный гель против сухости влагалища с прямым и отсроченным эффектом
DOP2016000100A (es) Agentes inductores de apoptosis para el tratamiento del cáncer y de enfermedades inmunes y autoinmunes
EA201591198A1 (ru) Антитела к gdf15
UY34811A (es) Compuestos y composiciones para inhibir la actividad de la abl1, abl2 y bcr-abl1
EA201291034A1 (ru) АПТАМЕРЫ К β-NGF И ИХ ПРИМЕНЕНИЕ ПРИ ЛЕЧЕНИИ B-NGF-ОПОСРЕДОВАННЫХ ЗАБОЛЕВАНИЙ И РАССТРОЙСТВ
SG10201803862UA (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
BR112013016905A2 (pt) métodos para diminuir incidência de enterocolite necrosante em bebês, crianças pequenas, ou crianças usando oligossacarídeos do leite humano
EA201270566A1 (ru) Противомикробные соединения и способы их получения и применения
EA201270567A1 (ru) Противомикробные соединения и способы их получения и применения
EA201391536A1 (ru) Противомикробные соединения и способы их получения и применения
BR112012029521A2 (pt) leucocidinas do staphylococcus aureus, composições terapêuticas, e aplicações das mesmas.
EA201291038A1 (ru) Соединения пиразола в качестве ингибиторов jak
EA201490610A1 (ru) Соединения и способы усиления врожденных иммунных ответов
MX2013003635A (es) Compuestos de n-heteroarilo.
EA201400748A1 (ru) Композиция для обработки семян
EA201590562A1 (ru) Бензамиды
IN2014DN10639A (ru)
EA201591345A1 (ru) Способы лечения фиброза и рака
MX2014003051A (es) Composiciones para el tratamiento de ulceras perifericas de diversos origenes.
UA107155C2 (uk) Стабільна композиція для лікування герпесвірусних інфекцій
EA201492280A1 (ru) Стабильный состав пексиганана
EA201591192A1 (ru) Антибактериальные соединения
EA201492173A1 (ru) Дронедарон для применения при лейшманиозе, в составах и комбинациях для применения при лейшманиозе
EA201590260A1 (ru) СОЕДИНЕНИЯ НА ОСНОВЕ ПЕПТИДОВ И ИХ ПРИМЕНЕНИЯ ДЛЯ ЛЕЧЕНИЯ АККУМУЛЯЦИИ β-АМИЛОИДА
BR112012031136A2 (pt) agentes anti-inflamatórios